Description

Unisia (Amlodipine + Candesartan)- Drug Insight, 2018 Description

IntroductionDelveInsight's pharmaceuticals report, Unisia (Amlodipine + Candesartan) Drug Insight, 2018 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Unisia (Amlodipine + Candesartan) covering the historical global sales and also provides the Unisia (Amlodipine + Candesartan) sales estimation during the forecasted period (2018-2020). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Unisia (Amlodipine + Candesartan) and emerging therapies in this space.

MethodologyThe report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope• A review of the Unisia (Amlodipine + Candesartan), based on information derived from company and industry-specific sources• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification• Coverage of the Drug Master Files and API Manufacturers by country• Patent Expiry Timeline and Exclusivity Details• Route of Synthesis of the API• Forecasted Sales Figure from 2018-2020• Market competition and emerging therapies • SWOT Analysis

Reasons to Buy• Establish a comprehensive understanding of Unisia (Amlodipine + Candesartan)• Access to drug`s API manufacturers details to devise API procurement strategy for generic development• Plan developmental timelines around drug`s patents for the major markets- US and EU • Understand Unisia (Amlodipine + Candesartan)`s current and future growth through its historical and forecasted sales• Identify and understand the current in-market competitors for the drug • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug• Identify opportunities in the same area as Unisia (Amlodipine + Candesartan) with DelveInsight`s SWOT analysis